Brief Research Report
Published on 10 Aug 2021
LEAP2 Impairs the Capability of the Growth Hormone Secretagogue Receptor to Regulate the Dopamine 2 Receptor Signaling
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2021.712437
- 5,230 views
- 30 citations





